Proton Beam Therapy
Adam Yauch aka MCA of Beastie Boys fame is dead at 47. He had cancer of the parotid gland with lymph node involvement although that has not yet been ruled the cause of his death.
RIP
Comments
-
you know, that is the theory
less scatter. Less collateral damage. Not availabe where I was treated, and not discussed. I did a literaypture review awhile back, and there isnt a lot of published data yet for head and neck. Bet it is in the future though.0 -
Proton Beam Therapy
jtl,
The motivation behind the introduction of PBT is diminished side effects of treatment, since protons have no exit dose and less entrance dose than conventional X-ray based radiation therapy. Head and neck cancers are one of the primary indications for PBT. For starters, one can see the (clinical summary) paper published by researchers at UPENN on www.frontiersin.org (September 2011, Volume 1, Article 24). And for Pat, it is interesting to note that re-irradiation is one of the primary indications for PBT. UPENN expects that up to 50% of their patients may be re-irradiation cases. That's because PBT introduces less toxicity into surrounding tissues. This is important because often times, patients are told when a re-occurance is discovered that there are no treatment options that could be safely administered. PBT is new hope for previously irradiated cases. PBT adoption has been slow, primarily because of higher priced equipment and a limited number of institutions able to afford it. But there are newer, more financially viable systems now available. PBT will save money in the long-term for healthcare expenditures in society, since the treatment & management of treatment-related side effects will be eliminated or diminished (depending on the cancer site, stage, etc.). Practitioners should run, not walk, toward adoption of this promising cancer therapy. PBT will lower the costs of healthcare and improve quality-of-life for cancer patients. This is undisputed for pediatrics, and the evidence is now trickling out for adults as well.0 -
More ammo is good in aPTadvocate said:Proton Beam Therapy
jtl,
The motivation behind the introduction of PBT is diminished side effects of treatment, since protons have no exit dose and less entrance dose than conventional X-ray based radiation therapy. Head and neck cancers are one of the primary indications for PBT. For starters, one can see the (clinical summary) paper published by researchers at UPENN on www.frontiersin.org (September 2011, Volume 1, Article 24). And for Pat, it is interesting to note that re-irradiation is one of the primary indications for PBT. UPENN expects that up to 50% of their patients may be re-irradiation cases. That's because PBT introduces less toxicity into surrounding tissues. This is important because often times, patients are told when a re-occurance is discovered that there are no treatment options that could be safely administered. PBT is new hope for previously irradiated cases. PBT adoption has been slow, primarily because of higher priced equipment and a limited number of institutions able to afford it. But there are newer, more financially viable systems now available. PBT will save money in the long-term for healthcare expenditures in society, since the treatment & management of treatment-related side effects will be eliminated or diminished (depending on the cancer site, stage, etc.). Practitioners should run, not walk, toward adoption of this promising cancer therapy. PBT will lower the costs of healthcare and improve quality-of-life for cancer patients. This is undisputed for pediatrics, and the evidence is now trickling out for adults as well.
More ammo is good in a battle.0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards